Panacea Biotec Ltd. | Small-cap | Healthcare
₹408.25
-3.75%
| Panacea Biotec Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 5.6B
Gross Profit 3.6B 64.31%
Operating Income -607.2M -10.86%
Net Income -87.2M -1.56%
EPS (Diluted) -₹1.37

Balance Sheet Metrics

Total Assets 12.9B
Total Liabilities 4.6B
Shareholders Equity 8.3B
Debt to Equity 0.55

Cash Flow Metrics

Operating Cash Flow -1.5B
Free Cash Flow -776.8M

Revenue & Profitability Trend

Panacea Biotec Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 5.6B 5.5B 4.6B 6.6B 6.2B
Cost of Goods Sold 2.0B 2.7B 2.8B 3.2B 2.3B
Gross Profit 3.6B 2.8B 1.8B 3.4B 3.9B
Operating Expenses 2.1B 1.4B 1.2B 1.6B 1.5B
Operating Income -607.2M -442.2M -1.1B -518.2M 367.2M
Pre-tax Income -79.5M 14.8M 128.0M 14.5B -1.4B
Income Tax 7.7M 29.8M 465.5M 3.7B 19.6M
Net Income -87.2M -15.0M -337.4M 10.8B -1.5B
EPS (Diluted) -₹1.37 -₹0.19 -₹5.43 ₹176.05 -₹24.11

Income Statement Trend

Panacea Biotec Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 5.5B 4.9B 5.7B 9.9B 5.1B
Non-Current Assets 7.4B 7.6B 7.0B 7.7B 6.7B
Total Assets 12.9B 12.4B 12.7B 17.6B 11.8B
Liabilities
Current Liabilities 3.7B 3.1B 3.3B 7.8B 4.5B
Non-Current Liabilities 921.4M 936.1M 992.2M 1.1B 9.6B
Total Liabilities 4.6B 4.0B 4.3B 8.9B 14.1B
Equity
Total Shareholders Equity 8.3B 8.4B 8.4B 8.7B -2.3B

Balance Sheet Composition

Panacea Biotec Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income -79.5M 14.8M 128.0M 14.5B -1.5B
Operating Cash Flow -1.5B -41.6M -70.2M 15.5B -79.0M
Investing Activities
Capital Expenditures -497.3M -710.4M -14.4M -105.1M -175.1M
Investing Cash Flow 572.7M 18.5M 4.2B 12.8B -511.1M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 0 -2.4M -147.7M -7.9B 487.2M
Free Cash Flow -776.8M -778.2M -4.6B -1.2B 850.0M

Cash Flow Trend

Panacea Biotec Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 91.93
Price to Book 3.11
Price to Sales 4.67
PEG Ratio 0.15

Profitability Ratios

Profit Margin -1.50%
Operating Margin -26.64%
Return on Equity -1.05%
Return on Assets -3.00%

Financial Health

Current Ratio 1.49
Debt to Equity 2.67
Beta 0.45

Per Share Data

EPS (TTM) -₹1.36
Book Value per Share ₹136.92
Revenue per Share ₹91.51

Financial data is updated regularly. All figures are in the company's reporting currency.